| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 05/17/2001 | WO2001022992A3 Influenza vaccine |
| 05/17/2001 | WO2001009309A3 RESCUE OF MUMPS VIRUS FROM cDNA |
| 05/17/2001 | US20010001290 Methods for enhancing the production of viral vaccines in cell culture |
| 05/17/2001 | DE19952982A1 Verfahren zur gerichteten Verpackung von molekularen Substanzen in Proteinhüllen Method for the directed packaging of molecular substances in protein shells |
| 05/17/2001 | DE19952957A1 Modulare Transportsysteme für molekulare Substanzen und deren Herstellung und Verwendung Modular Transport systems for molecular substances and their production and use |
| 05/16/2001 | EP1098981A1 A mutant human hepatitis b viral strain and uses thereof |
| 05/16/2001 | EP1098961A1 Interferon inducing genetically engineered attenuated viruses |
| 05/16/2001 | CN1295620A Protein expression in baculovirus vector expression system |
| 05/16/2001 | CN1295612A Mutant herpes simplex viruses and uses thereoe |
| 05/16/2001 | CN1065912C Genetically engineered attenuated viruses |
| 05/15/2001 | US6232120 Methods to inhibit replication of infective virus |
| 05/15/2001 | US6232099 Method of producing a chimeric protein |
| 05/15/2001 | US6231868 Method for generating nonpathogenic infections birnavirus from synthetic RNA transcripts |
| 05/15/2001 | US6231850 Canine interleukin 12 |
| 05/15/2001 | CA1341234C Recombinant fowlpox virus |
| 05/10/2001 | WO2001032899A1 Gene transfer method |
| 05/10/2001 | WO2001032852A2 Method for directed packaging of molecular substances in protein shells |
| 05/10/2001 | WO2001032851A2 Modular transport systems for molecular substances and production and use thereof |
| 05/10/2001 | WO2001032702A2 Molecular structure of rhd negative locus |
| 05/10/2001 | WO2001032224A1 Method of inactivating pathogens |
| 05/10/2001 | CA2388028A1 Method of inactivating pathogens |
| 05/09/2001 | EP1097988A1 Process for culturing cells in a monolayer |
| 05/09/2001 | CN1294628A Mutations responsible for attenuation in measles virus or human respiratory syncytial virus subgroup B |
| 05/08/2001 | US6228646 Recombinant adenovirus helper-dependent vector with adenovirus inverted terminal repeat sequences, at least one recombination site, and adenovirus packaging sequence, and exogenous dna to be expressed; simple and efficient production |
| 05/08/2001 | US6228368 Antigens for human papilloma virus capsomere and fusion proteins adjacent to amino acid residues |
| 05/03/2001 | WO2001031046A1 Invasive bacterial vectors for expressing alphavirus replicons |
| 05/03/2001 | WO2001030983A1 Method for purifying aav |
| 05/03/2001 | WO2001030847A1 Modified gp100 and uses thereof |
| 05/03/2001 | WO2001030382A1 Method of inducing and/or enhancing an immune response to tumor antigens |
| 05/03/2001 | WO2000068390A3 Plant recombination proteins |
| 05/03/2001 | WO2000054813A3 Use of recombinant gene delivery vectors for treating or preventing diseases of the eye |
| 05/03/2001 | CA2721011A1 Modified gp100 and uses thereof |
| 05/03/2001 | CA2388337A1 Method of inducing and/or enhancing an immune response to tumor antigens |
| 05/03/2001 | CA2387921A1 Invasive bacterial vectors for expressing alphavirus replicons |
| 05/02/2001 | EP1096018A1 Complementation cells comprising an inducer and/or a repressor |
| 05/02/2001 | EP1096014A2 Catalytic domain of the human effector cell cycle checkpoint protein kinase, Chk1, materials and methods for identification of inhibitors thereof |
| 05/02/2001 | EP1094837A2 Porcine circovirus and parvovirus vaccine |
| 05/02/2001 | EP0817860B1 Pseudotyped retroviral particles |
| 05/01/2001 | US6225289 Methods and compositions for preserving adenoviral vectors |
| 05/01/2001 | US6225111 Expression vector for the expression of heterologous proteins |
| 05/01/2001 | US6225066 Determining drug resistance by incubating strain with drug and temperate mycobacteriophage permiting formation of lysogens which express reporter gene, then detecting transcription of reporter gene as indicator of resistance |
| 05/01/2001 | US6225048 Culturing monocytes in fluid communication with viable, allogenically stimulated peripheral blood mononuclear cells to cause differentiation into macrophages, then permitting replication of latent or exogenous virus |
| 05/01/2001 | US6224879 Genetic engineering |
| 05/01/2001 | CA2067333C Production of genetically-engineered vaccines for aids and retroviral diseases |
| 04/26/2001 | WO2001029194A1 Porcine endogenous retrovirus (poerv) expressed in guinea pig and corresponding animal models |
| 04/26/2001 | WO2001028585A1 Novel process for making human papillomavirus virus-like particles with improved properties |
| 04/26/2001 | CA2384844A1 Novel process for making human papillomavirus virus-like particles with improved properties |
| 04/25/2001 | EP1093524A1 Recombinant herpes viruses for preparing recombinant adeno-associated viruses |
| 04/25/2001 | EP1093519A2 Amphiphilic peptides derived from the cytoplasmic tail of viral envelope proteins |
| 04/25/2001 | CN1292817A Novel recombinant baculovirus, construction method thereof and insect pesticidal composition containing same |
| 04/24/2001 | US6221646 Materials and methods for simplified AAV production |
| 04/24/2001 | US6221361 A vector for the delivery of vaccine antigens and therapeutic agents to swine. |
| 04/24/2001 | US6221360 Infectious bovine rhinotracheitis vaccines and methods |
| 04/19/2001 | WO2001027304A2 Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex dna |
| 04/19/2001 | WO2001027303A1 Adeno-associated virus vectors encoding factor viii and methods of using the same |
| 04/19/2001 | WO2001027302A1 Recombinant, replication defective celo virus and celo virus dna |
| 04/19/2001 | WO2001027301A2 System for rapid generation of recombinant baculovirus-based expression vectors for silkworm larvae |
| 04/19/2001 | WO2001027300A1 Lentiviral vectors for the preparation of immunotherapeutical compositions |
| 04/19/2001 | WO2001027292A2 Methods and compositions for targeting a cell |
| 04/19/2001 | WO2001027282A1 Plant virus particles with exogenous internal eitopes |
| 04/19/2001 | WO2000071078A3 Composition designed for implementing an antitumoral or antiviral treatment in a mammal |
| 04/19/2001 | DE19947668A1 Tumorspezifischer Vektor für die Gentherapie A tumor-specific vector for gene therapy |
| 04/19/2001 | CA2387626A1 Viral particles with exogenous internal epitopes |
| 04/19/2001 | CA2387484A1 Adeno-associated virus vectors encoding factor viii and methods of using the same |
| 04/19/2001 | CA2386824A1 Methods and compositions for targeting a cell |
| 04/19/2001 | CA2384805A1 Recombinant, replication defective celo virus and celo virus dna |
| 04/18/2001 | EP1092780A1 Recombiant, replication defective CELO virus and CELO virus DNA |
| 04/18/2001 | EP1092779A1 Lentiviral vectors for the preparation of immunotherapeutical compositions |
| 04/18/2001 | EP1092775A1 Methods for identifiying non-essential genes of the human cytomegalovirus genome and for screening for inhibitors of human cytomegalovirus |
| 04/18/2001 | EP1092770A2 Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same |
| 04/18/2001 | EP1092035A2 Targeted integration into chromosomes using retroviral vectors |
| 04/18/2001 | EP1092031A2 Marburg virus vaccines |
| 04/18/2001 | EP1091765A1 Methods for reducing adventitious agents and toxins and cell culture reagents produced thereby |
| 04/18/2001 | CN1292027A Method and apparatus for irradiating biological fluid |
| 04/18/2001 | CN1291649A Genetically engineered virus of Chinese ballworm |
| 04/17/2001 | US6218372 Methods for treating restenosis with p21 |
| 04/17/2001 | US6218187 Infect human stem cells with microoganism supernatant; transfect cells, separate cells from supernatant, add adhesion molecules to culture plates, propagate second group of cells with supernantant and recover transduced cells |
| 04/17/2001 | US6218181 Retroviral packaging cell line |
| 04/17/2001 | US6218180 Virion coding a toxic agent, cytokine and tumor suppressor; for the treatment of tumorous defects; antitumor agents |
| 04/17/2001 | US6217883 Immunology response |
| 04/17/2001 | US6217882 Inserting heterogeneity nucleotide sequence |
| 04/12/2001 | WO2001025484A2 Methods to inhibit or enhance the binding of viral dna to genomic host dna |
| 04/12/2001 | WO2001025466A1 Producer cell for the production of retroviral vectors |
| 04/12/2001 | WO2001025465A1 Adeno-associated viruses and uses thereof |
| 04/12/2001 | WO2001025464A1 Materials and methods for simplified aav production |
| 04/12/2001 | WO2001025463A1 Recombinant adenoviruses preparation and adenovirus banks |
| 04/12/2001 | WO2001025462A1 Production of recombinant aav using adenovirus comprising aav rep/cap genes |
| 04/12/2001 | WO2001025441A2 Tumour-specific vector for gene therapy |
| 04/12/2001 | WO2001025433A2 Novel polypeptides, their nucleic acids, and methods for their use in angiogenesis and vascularization |
| 04/12/2001 | WO2001025416A1 Recombinant double hybrid filamentous bacteriophage |
| 04/12/2001 | WO2000057907A3 Multivalent dengue virus vaccine |
| 04/12/2001 | WO2000049166A3 Production of helper dependent adenovirus vectors based on use of endonucleases |
| 04/12/2001 | WO2000026667A9 Variable heavy chain and variable light chain regions of antibodies to human platelet glycoprotein ib alpha |
| 04/12/2001 | WO2000000616A9 Marburg virus vaccines |
| 04/12/2001 | WO1997004099A3 Papillomaviruses, agents for detecting them and for treating diseases caused by such viruses |
| 04/12/2001 | CA2386722A1 Materials and methods for simplified aav production |
| 04/12/2001 | CA2386546A1 Adeno-associated viruses and uses thereof |
| 04/12/2001 | CA2385823A1 Production of recombinant aav using adenovirus comprising aav rep/cap genes |
| 04/12/2001 | CA2382859A1 Novel polypeptides, their nucleic acids, and methods for their use in angiogenesis and vascularization |
| 04/11/2001 | EP1091000A1 An attenuated vaccination and gene-transfer virus, a method to make the virus and a pharmaceutical composition comprising the virus |